-+ 0.00%
-+ 0.00%
-+ 0.00%

AbCellera appoints Victor Sandor to board as independent director

PUBT·06/05/2026 13:00:50
Listen to the news
AbCellera appoints Victor Sandor to board as independent director
  • AbCellera appointed Victor Sandor, M.D.C.M., to its board as an independent director.
  • Sandor was chief medical officer at Array BioPharma before its acquisition by Pfizer.
  • He previously led global clinical development at Incyte, supporting the approval of Jakafi (ruxolitinib).
  • Sandor also held senior oncology roles at Biogen, with earlier positions at AstraZeneca.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260605492754) on June 05, 2026, and is solely responsible for the information contained therein.